Tuesday, 1 July 2014

1°-Is Cystic fibrosis disease a potential target for Biocontrol?

old post:
Sunday, 18 July 2010

Historical document
(phage administration in humans)


AD NUMBER
AD837021







Diriphagen


"We used the preparation (Diriphagen : Dr.Heinz Haury Chemical Plant, Munich) because we believed that this preparation met the requirements we just set up. According to Information received, this preparation contains 180-200 different phage strains and thus has a broad spectrum of effectiveness"


Today........

From:

Toward Modern Inhalational Bacteriophage Therapy:Nebulization of Bacteriophages of Burkholderia cepacia Complex
"The results suggest that BCC bacteriophages can be nebulized successfully within a reasonable delivery time and predicted titers in the lung indicate that this method may hold potential for treatment of bacterial lung infections common among cystic fibrosis patients"